Literature DB >> 34090052

Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model.

Shaimaa H Gadallah1, Sanaa Eissa2, Hala M Ghanem3, Emad K Ahmed4, Amany Helmy Hasanin5, Manal M El Mahdy6, Marwa Matboli7.   

Abstract

AIM: To investigate the prophylactic efficacy of gut microbiota-based treatments on nonalcoholic steatohepatitis (NASH) management via modulation of Hippo signaling pathway-related genes (YAP1, LATS1 and NF2), and their epigenetic regulators (miR-1205 and lncRNA SRD5A3-AS1) retrieved from in-silico data analysis. MATERIALS &
METHODS: Histopathological, biochemical, molecular and immunohistochemistry analyses were used to assess the effects of multistrain probiotic mixture and prebiotic inulin fiber on high sucrose high fat (HSHF) diet-induced NASH in rats. These treatments were administered orally either alone or in combination, along with HSHF diet.
RESULTS: Both probiotic mixture and prebiotic inulin fiber attenuated steatosis, inflammation and fibrosis grades in HSHF diet-induced NASH rats. Moreover, the applied treatments significantly prevented the elevation of serum liver enzymes and improved lipid panel. At the molecular level, both treatments down-regulated hepatic YAP1 mRNA and miR-1205 expressions, and concomitantly up-regulated the expression of hepatic LATS1& NF2 mRNAs and the lncRNA SRD5A3-AS1. At the protein level, both treatments decreased the hepatic content of the inflammatory marker IL6 and the fibrotic marker TGFβ1. Moreover, an observable reduction in α-SMA together with noticeable elevation in LATS1/2 protein expression levels were detected in liver sections compared to the untreated rats.
CONCLUSION: Probiotic mixture and prebiotic inulin fiber, either alone or in combination, attenuated NASH progression and ameliorated both fibrosis and hepatic inflammation in the applied animal model. The produced effect was correlated with modulation of the retrieved (YAP1, LATS1 and NF2) - (miR-1205) - (lncRNA SRD5A3-AS1) RNA panel.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Hippo signaling; NASH; Prebiotic; Probiotic; Synbiotic

Year:  2021        PMID: 34090052     DOI: 10.1016/j.biopha.2021.111781

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death.

Authors:  Reda Albadawy; Amany Helmy Hasanin; Sara H A Agwa; Shaimaa Hamady; Yasmin M Aboul-Ela; Mona Hussien Raafat; Samaa Samir Kamar; Mohamed Othman; Yahia A Yahia; Marwa Matboli
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 2.  Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role.

Authors:  Haripriya Gupta; Byeong-Hyun Min; Raja Ganesan; Yoseph Asmelash Gebru; Satya Priya Sharma; Eunju Park; Sung-Min Won; Jin-Ju Jeong; Su-Been Lee; Min-Gi Cha; Goo-Hyun Kwon; Min-Kyo Jeong; Ji-Ye Hyun; Jung-A Eom; Hee-Jin Park; Sang-Jun Yoon; Mi-Ran Choi; Dong-Joon Kim; Ki-Tae Suk
Journal:  Biomedicines       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.